# Can You Switch From Semaglutide to Tirzepatide? | Buy This GLP

What studies in adults with type 2 diabetes found about switching to tirzepatide or starting it after prior GLP-1 use.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Can You Switch From Semaglutide to Tirzepatide?

A short switch study and a matched type 2 diabetes cohort answer different questions about weight and blood sugar after prior GLP-1 use.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Weight lost at twelve months, kilograms · tirzepatide, no recent use · 10.2 · semaglutide, no recent use · 6.1 · tirzepatide, used one before · 7.9 · semaglutide, used one before · 3.7 · Adults with type 2 diabetes and two recorded weights.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

A prescriber can consider switching from semaglutide to tirzepatide when tirzepatide is appropriate for the condition being treated. The U.S. prescribing information for Zepbound advises against combining it with a GLP-1 receptor agonist such as semaglutide [\[3\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-3). The prescriber can plan the change around the current product, side effects and other medicines.

## Key takeaways

-   A 12-week study followed adults with type 2 diabetes who switched from a GLP-1 medicine to tirzepatide. It had no group that stayed on its previous treatment.
-   A separate matched study found greater weight loss with tirzepatide than injectable semaglutide among patients with and without prior GLP-1 use.
-   Comparisons between groups cannot predict what a particular person will lose after a switch.

## What a prospective switch study found

The evidence on [switching in the reverse direction](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide) comes from different studies. In a prospective 12-week study of 152 adults with type 2 diabetes, participants changed from a stable GLP-1 prescription to tirzepatide. Prior medicines included injectable semaglutide, dulaglutide and liraglutide [\[2\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-2).

Mean HbA1c declined by 0.43 percentage points and weight by 2.15 kg at week 12. These were overall changes from baseline across the prior medicines. The study did not include a group continuing semaglutide, so it cannot show how much of the change the switch itself added [\[2\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-2).

## How prior use changed the comparison

In a separate observational study of people with type 2 diabetes, researchers checked for GLP-1 prescription fills in the previous six months. Those with prior fills lost 7.9 kg after starting tirzepatide and 3.7 kg after starting injectable semaglutide at 12 months. The corresponding changes among people without fills in that period were 10.2 kg and 6.1 kg [\[1\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-1).

The weight results used participants with both baseline and follow-up measurements. In the prior-use groups, that meant 296 on tirzepatide and 224 on semaglutide out of 5,577 matched participants per group. In the groups without prior use, 454 and 432 participants had both weights out of 10,702 per group [\[1\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-1).

Why the two results answer different questions

The matched study grouped people by previous GLP-1 use. It did not test switching specifically from semaglutide to tirzepatide against staying on semaglutide. Differences in people who received each prescription or returned for weighing could influence the averages [\[1\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-1).

## What to discuss before a change

The [GLP-1 insurance guide](https://buythisglp.com/research/does-insurance-cover-glp1) explains how coverage can depend on the product and diagnosis. If cost or availability is the issue, check coverage for the proposed prescription. Your prescriber can review your response, side effects and whether other diabetes medicines need closer monitoring[\[3\]](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide#ref-3).

## Frequently asked

Can you switch from semaglutide to tirzepatide?

A prescriber can consider switching if tirzepatide fits your treatment goals and medical history. The Zepbound label advises against combining it with a GLP-1 medicine such as semaglutide.

How much weight can you lose after switching?

In one uncontrolled 12-week study of adults with type 2 diabetes changing from several GLP-1 medicines to tirzepatide, average weight fell 2.15 kg. That result cannot predict individual weight loss after switching from semaglutide.

## Sources

1.  \[1\] Hoog MM, et al. (2025). Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes Diabetes Therapy. [PMID 41066072](https://link.springer.com/article/10.1007/s13300-025-01794-9)
2.  \[2\] Jabbour S, Paik JS, Aleppo G, et al. (2024). Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment Endocrine Practice. [PMID 38723893](https://pubmed.ncbi.nlm.nih.gov/38723893/)
3.  \[3\] Eli Lilly and Company (2026). Zepbound prescribing information DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
